Dapsone Gel
Payment Trends by Year
| Year | Amount | Transactions | Doctors |
|---|---|---|---|
| 2017 | $245,777 | 4 | 0 |
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $245,777 | 4 | 100.0% |
Research Studies & Clinical Trials
| Study Name | Sponsor | Amount | Doctors |
|---|---|---|---|
| Randomized, Open-Label, 2-way Crossover Bioequivalence Study of Dapsone Gel, 5% Manufactured by Amneal Pharmaceuticals and ACZONE (dapsone) Gel, 5% Marked by Allergan, Inc. Following a 3-Gram Dose to Healthy Subjects (172005) | Amneal Pharmaceuticals LLC | $245,083 | 0 |
| Pilot, Randomized, Open-Label, 2-way Crossover Comparative Bioequivalence Study of Dapsone Gel, 5% and ACZONE (dapsone) Gel, 5% (Reference) Following a 3 Grams Dose to Healthy Subjects (162005) | Amneal Pharmaceuticals LLC | $694.47 | 0 |
Top Doctors Receiving Payments for Dapsone Gel
| Doctor | Specialty | Location | Total | Records |
|---|---|---|---|---|
| Unknown | — | — | $245,777 | 4 |
Manufacturing Companies
- Amneal Pharmaceuticals LLC $245,777
Product Information
- Type Drug
- Total Payments $245,777
- Total Doctors 0
- Transactions 4
About Dapsone Gel
Dapsone Gel is a drug associated with $245,777 in payments to 0 healthcare providers, recorded across 4 transactions in the CMS Open Payments database. The primary manufacturer is Amneal Pharmaceuticals LLC.
Payment data is available from 2017 to 2017. In 2017, $245,777 was paid across 4 transactions to 0 doctors.
The most common payment nature for Dapsone Gel is "Unspecified" ($245,777, 100.0% of total).
Dapsone Gel is associated with 2 research studies, including "Randomized, Open-Label, 2-way Crossover Bioequivalence Study of Dapsone Gel, 5% Manufactured by Amneal Pharmaceuticals and ACZONE (dapsone) Gel, 5% Marked by Allergan, Inc. Following a 3-Gram Dose to Healthy Subjects (172005)" ($245,083).